Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer

被引：2
|
作者：
Gouda, M. A. [1 ]
Sherman, E. J. [2 ]
Gilcrease, G. W. [3 ]
Vaishampayan, U. N. [4 ]
Parikh, A. [5 ]
Feun, L. [6 ]
Kummar, S. [7 ]
Huang, H. [1 ]
Zhang, C. [8 ]
Severson, P. [8 ]
Inokuchi, K. [8 ]
Silverman, M. [8 ]
Bollag, G. [8 ]
Janku, F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[2] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA
[3] Huntsman Canc Inst, Med Oncol, Salt Lake City, UT USA
[4] Univ Michigan, Div Hematol Oncol, Michigan Med, Ann Arbor, MI 48109 USA
[5] Massachusetts Gen Hosp, Med Oncol, Boston, MA 02114 USA
[6] Sylvester Comprehens Canc Ctr, Hematol Oncol, Miami, FL USA
[7] Stanford Univ, Med Oncol, Palo Alto, CA 94304 USA
[8] Plexxikon Inc, Berkeley, CA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
529MO
引用
收藏
页码：S465 / S465
页数：1
相关论文
共 50 条
  • [31] Serial ctDNA (circulating tumour DNA) for detection of genomic changes during neoadjuvant chemoradiotherapy (NACRT) in locally advanced rectal cancer (LARC)
    Lee, C. L.
    Toomey, S.
    O'Neill, B.
    Hennessy, B. T.
    ANNALS OF ONCOLOGY, 2020, 31 : S423 - S424
  • [32] Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
    Eyck, Ben M.
    Jansen, Maurice P. H. M.
    Noordman, Bo Jan
    Atmodimedjo, Peggy N.
    van der Wilk, Berend J.
    Martens, John W. M.
    Helmijr, Jean A.
    Beaufort, Corine M.
    Mostert, Bianca
    Doukas, Michail
    Wijnhoven, Bas P. L.
    Lagarde, Sjoerd M.
    van Lanschot, J. Jan B.
    Dinjens, Winand N. M.
    JOURNAL OF PATHOLOGY, 2023, 259 (01): : 35 - 45
  • [33] Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
    Kim, Yoo-Na
    Shim, Yeeun
    Lee, Jung-Yun
    Lee, Seung-Tae
    Seo, Jieun
    Lee, Yong Jae
    Shin, Saeam
    Kim, Sang Wun
    Choi, Jong Rak
    Kim, Sunghoon
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S20 - S20
  • [34] Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
    Kim, Y-N.
    Shim, Y.
    Lee, J-Y.
    Lee, S-T.
    Seo, J.
    Lee, Y. J.
    Shin, S.
    Kim, S. W.
    Choi, J. R.
    Kim, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S746 - S746
  • [35] Circulating tumor-derived DNA (ctDNA) clearance in patients with locally advanced rectal cancer treated with multimodal treatment
    Gervaso, L.
    Ciardiello, D.
    Ascione, L.
    Boldrini, L.
    Guidi, L.
    Valenza, C.
    Gregato, G.
    Funicelli, L.
    Bottiglieri, L.
    De Roberto, G.
    Petz, W.
    Borin, S.
    Romario, U. Fumagalli
    Gerardi, M.
    Bertolini, F.
    Curigliano, G.
    Fazio, N.
    Zampino, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S48 - S48
  • [36] Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC)
    Tie, J.
    Cohen, J.
    Lahouel, K.
    Lo, S. N.
    Wang, Y.
    Wong, R.
    Shapiro, J.
    Harris, S.
    Khattak, A.
    Burge, M.
    Horvath, L. G.
    Karapetis, C. S.
    Shannon, J.
    Singh, M.
    Yip, D.
    Papadopoulos, N.
    Tomasetti, C.
    Kinzler, K.
    Vogelstein, B.
    Gibbs, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S683 - S683
  • [37] Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
    Chabon, Jacob J.
    Simmons, Andrew D.
    Lovejoy, Alexander F.
    Esfahani, Mohammad S.
    Newman, Aaron M.
    Haringsma, Henry J.
    Kurtz, David M.
    Stehr, Henning
    Scherer, Florian
    Karlovich, Chris A.
    Harding, Thomas C.
    Durkin, Kathleen A.
    Otterson, Gregory A.
    Purcell, W. Thomas
    Camidge, D. Ross
    Goldman, Jonathan W.
    Sequist, Lecia V.
    Piotrowska, Zofia
    Wakelee, Heather A.
    Neal, Joel W.
    Alizadeh, Ash A.
    Diehn, Maximilian
    NATURE COMMUNICATIONS, 2016, 7
  • [38] Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
    Jacob J. Chabon
    Andrew D. Simmons
    Alexander F. Lovejoy
    Mohammad S. Esfahani
    Aaron M. Newman
    Henry J. Haringsma
    David M. Kurtz
    Henning Stehr
    Florian Scherer
    Chris A. Karlovich
    Thomas C. Harding
    Kathleen A. Durkin
    Gregory A. Otterson
    W. Thomas Purcell
    D. Ross Camidge
    Jonathan W. Goldman
    Lecia V. Sequist
    Zofia Piotrowska
    Heather A. Wakelee
    Joel W. Neal
    Ash A. Alizadeh
    Maximilian Diehn
    Nature Communications, 7
  • [39] Circulating cell free tumor DNA: dynamics in patients with advanced and localized cancer disease
    Hilke, F. J.
    Zwirner, K.
    Bitzer, M.
    Malek, N.
    Kootz, B.
    Stephan, O.
    Gani, C.
    Riess, O.
    Zips, D.
    Welz, S.
    Christopher, S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 190 - 191
  • [40] Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
    Louveau, Baptiste
    Tost, Jorg
    Mauger, Florence
    Sadoux, Aurelie
    Podgorniak, Marie-Pierre
    How-Kit, Alexandre
    Pages, Cecile
    Roux, Jennifer
    Da Meda, Laetitia
    Lebbe, Celeste
    Mourah, Samia
    ESMO OPEN, 2017, 2 (02)
12345